It will start recruiting volunteers this month, it said in a release published on China's WeChat messaging app platform. Last week, Brazil gave the go-ahead for the company to start testing volunteers in the country. AstraZeneca's experimental COVID-19 vaccine, which was developed by researchers at the University of Oxford, and Sinopharm are the only other candidates in late-stage Phase III trials. Phase I and Phase II trials typically test the safety of a drug before it enters Phase III trials that test its efficacy. No COVID-19 vaccine has yet been approved for commercial use.

Source: bd News24 July 06, 2020 13:41 UTC